Stock Analysis

Aptamer Group First Half 2023 Earnings: UK£0.038 loss per share (vs UK£0.018 loss in 1H 2022)

Source: Shutterstock

Aptamer Group (LON:APTA) First Half 2023 Results

Key Financial Results

  • Revenue: UK£1.02m (down 26% from 1H 2022).
  • Net loss: UK£2.63m (loss widened by 139% from 1H 2022).
  • UK£0.038 loss per share (further deteriorated from UK£0.018 loss in 1H 2022).
AIM:APTA Earnings and Revenue History March 17th 2023

All figures shown in the chart above are for the trailing 12 month (TTM) period

Aptamer Group Earnings Insights

Looking ahead, revenue is forecast to grow 61% p.a. on average during the next 2 years, compared to a 14% growth forecast for the Biotechs industry in the United Kingdom.

Performance of the British Biotechs industry.

The company's shares are down 23% from a week ago.

Risk Analysis

What about risks? Every company has them, and we've spotted 5 warning signs for Aptamer Group (of which 3 make us uncomfortable!) you should know about.

Valuation is complex, but we're helping make it simple.

Find out whether Aptamer Group is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis